| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $18.9M | -39.5% |
| R&D Expense | $13.7M | -25.9% |
| SG&A Expense | $39.1M | -4.2% |
| Operating Income | -$259.1M | -205.3% |
| Pre-tax Income | -$249.1M | -200.0% |
| Income Tax | $621K | -7.2% |
| Net Income | -$249.7M | -198.3% |
| EPS (Basic) | -$50.55 | -8615.5% |
| EPS (Diluted) | -$50.55 | -8615.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $32.9M | -41.5% |
| Accounts Receivable | $13.0M | -32.0% |
| Inventory | $684K | -21.0% |
| Current Assets | $80.9M | -41.9% |
| Total Assets | $157.7M | -58.3% |
| Current Liabilities | $28.5M | +127.4% |
| Total Liabilities | $53.4M | +34.8% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$32.8M | +35.5% |
| Capital Expenditures | $30.2M | +237.4% |
| Investing Cash Flow | -$1.1M | -103.7% |
| Financing Cash Flow | $10.7M | +199.7% |
| Free Cash Flow | -$63.0M | -5.4% |
| $104.2M |
| -69.2% |